Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hamelin

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Cancer Genetics and Cytogenetics|December 22, 1999
TP53 status and gene amplification in human colorectal carcinomasP Soulié, E Fourme, R Hamelin, et al.
Oncogene|October 1, 1993
Frequently elevated content of immunochemically defined wild-type p53 protein in colorectal adenomasO Tominaga, R Hamelin, V Trouvat, et al.
Anticancer Research|November 1, 1990
Steroid hormone receptors and tumorigenicity of sublines from breast tumor metastatic MDA-MB 231 cell lineM Crépin, V Salle, H Raux, et al.
The Journal of Pathology|July 17, 1998
Mutation of the transforming growth factor-beta type II receptor gene in right-sided colorectal cancer: relationship to clinicopathological features and genetic alterationsB J Iacopetta, J Welch, R Soong, et al.
Oncogene|August 3, 1995
Frequent loss of heterozygosity on chromosome 9, and low incidence of mutations of cyclin-dependent kinase inhibitors p15 (MTS2) and p16 (MTS1) genes in gliomasY J Li, K Hoang-Xuan, J Y Delattre, et al.
Oncogene|December 19, 1996
Inverse correlation between RER+ status and p53 mutation in colorectal cancer cell linesP H Cottu, F Muzeau, A Estreicher, et al.
Oncogene|August 30, 2001
Extensive characterization of genetic alterations in a series of human colorectal cancer cell linesJ Gayet, X P Zhou, A Duval, et al.
Leukemia|January 24, 2017
Differential signaling networks of Bcr-Abl p210 and p190 kinases in leukemia cells defined by functional proteomicsS Reckel, R Hamelin, S Georgeon, et al.
Gastroenterology|October 1, 1994
TP53 gene mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's esophagusR Hamelin, J F Fléjou, F Muzeau, et al.
International Journal of Cancer|December 20, 1995
Incidence of germ-line p53 mutations in patients with gliomasY J Li, M Sanson, K Hoang-Xuan, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Cancer Genetics and Cytogenetics|December 22, 1999
TP53 status and gene amplification in human colorectal carcinomasP Soulié, E Fourme, R Hamelin, et al.
Oncogene|October 1, 1993
Frequently elevated content of immunochemically defined wild-type p53 protein in colorectal adenomasO Tominaga, R Hamelin, V Trouvat, et al.
Anticancer Research|November 1, 1990
Steroid hormone receptors and tumorigenicity of sublines from breast tumor metastatic MDA-MB 231 cell lineM Crépin, V Salle, H Raux, et al.
The Journal of Pathology|July 17, 1998
Mutation of the transforming growth factor-beta type II receptor gene in right-sided colorectal cancer: relationship to clinicopathological features and genetic alterationsB J Iacopetta, J Welch, R Soong, et al.
Oncogene|August 3, 1995
Frequent loss of heterozygosity on chromosome 9, and low incidence of mutations of cyclin-dependent kinase inhibitors p15 (MTS2) and p16 (MTS1) genes in gliomasY J Li, K Hoang-Xuan, J Y Delattre, et al.
Oncogene|December 19, 1996
Inverse correlation between RER+ status and p53 mutation in colorectal cancer cell linesP H Cottu, F Muzeau, A Estreicher, et al.
Oncogene|August 30, 2001
Extensive characterization of genetic alterations in a series of human colorectal cancer cell linesJ Gayet, X P Zhou, A Duval, et al.
Leukemia|January 24, 2017
Differential signaling networks of Bcr-Abl p210 and p190 kinases in leukemia cells defined by functional proteomicsS Reckel, R Hamelin, S Georgeon, et al.
Gastroenterology|October 1, 1994
TP53 gene mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's esophagusR Hamelin, J F Fléjou, F Muzeau, et al.
International Journal of Cancer|December 20, 1995
Incidence of germ-line p53 mutations in patients with gliomasY J Li, M Sanson, K Hoang-Xuan, et al.
Pageof 9